XML 74 R49.htm IDEA: XBRL DOCUMENT v3.24.1
Financial Statement Details - Accrued Expenses and Other Liabilities (Detail) - USD ($)
$ in Thousands
Dec. 31, 2023
Dec. 31, 2022
Financial Statement Details [Abstract]    
Accrued bonus $ 11,350 $ 12,068
Accrued professional and service fees 9,829 6,685
Accrued research and development costs 7,700 1,930
Accrued compensation 6,241 6,040
Accrued preclinical and clinical trial costs 4,218 4,985
Financing obligation – current portion 1,475 1,417
Accrued construction costs 1,179 7,072
Other 716 1,628
Accrued expenses and other liabilities $ 42,708 $ 41,825